NorthWest Biotherapeutics Inc (NWBO)

[KRISGO]

For me, it’s extremely frustrating, and I don’t even know where to place the blame—MHRA, the management’s behavior, or myself for staying invested for so long and continuing to add shares. Every time the stock starts to move up, I buy more, thinking things are finally turning around. October passed and we thought November would be better; November passed and we expected approval before the ASM. We believed LP would manage the shorts and handle PR effectively—but here we are after the ASM, with nothing happening except dilution.